Boston Common Asset Management, LLC - SHENZHEN MINDRAY BIO-MEDICA CNY 1.0 ownership

Back to all holdings Add to watchlist

SHENZHEN MINDRAY BIO-MEDICA CNY 1.0's ticker is and the CUSIP is Y774E3101. A total of 1 filers reported holding SHENZHEN MINDRAY BIO-MEDICA CNY 1.0 in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.3%.

Links
Filings
Quarter-by-quarter ownership
Boston Common Asset Management, LLC ownership history of SHENZHEN MINDRAY BIO-MEDICA CNY 1.0
ValueSharesWeighting
Q3 2023$4,320
-48.0%
116,654
-42.2%
0.10%
-41.8%
Q2 2023$8,310
-37.9%
201,654
-31.6%
0.18%
-36.3%
Q1 2023$13,376–294,694–0.28%–
 Download
Other shareholders
SHENZHEN MINDRAY BIO-MEDICA CNY 1.0 shareholders Q1 2023
NameSharesValueWeighting ↓
Stanley-Laman Group, Ltd. 12,900$785,0000.13%
View complete list of SHENZHEN MINDRAY BIO-MEDICA CNY 1.0 shareholders